RESUMO
This study aimed to determine the uptake of the post-partum intra-uterine contraceptive device (PPIUD) and characteristics of women choosing PPIUD. The authors evaluated safety, efficacy and satisfaction following PPIUD insertion via a prospective cohort study. 276 pregnant women (age: 16-50 years) gave informed consent and received a PPIUD. Follow up was between 6-8 weeks postpartum. The mean age was 25.8 years with 74.9% being gravida 2-4. The follow up rate was 60.5%. PPIUD was found to be safe and acceptable with 79.6% of participants experiencing no side effects and 74.3% expressing high satisfaction. No pregnancies were reported. Expulsions (n=15) were not associated with gravidity, parity, gestational age or medical and surgical risk factors. (p-value >0.05). PPIUD is a safe, effective and acceptable form of contraception. Participants experienced few side effects and high satisfaction. Low follow-up is a concern.
RESUMO
Implanon NXT was introduced in South Africa (SA) in 2014 to expand the contraceptive method mix. While studies have explored patterns of implant use, data on contraceptive choice following implant removal is limited. Here, we describe contraceptive choice among 120 women requesting Implanon NXT removal, between 2017 and 2018, at an urban reproductive health clinic in Durban, SA. Among women who used the implant for three years (n=91), >50% chose to reinsert Implanon NXT. Reasons for choosing to reinsert included satisfaction with the implant, the desire for a long-acting method and having had no side effects. A third of women chose not to reinsert Implanon NXT after three years due to side effects such as problematic bleeding. Most women requesting early removal of the implant switched to male condoms, injectables or oral contraceptives. Contraceptive services should provide women with contraceptive options and allow women to make informed decisions regarding contraceptive choice, in addition to providing support and managing side effects among Implanon NXT users.
Assuntos
Comportamento de Escolha , Anticoncepcionais Femininos/uso terapêutico , Contraceptivos Hormonais/uso terapêutico , Desogestrel/uso terapêutico , Remoção de Dispositivo , Preferência do Paciente , Adulto , Preservativos , Comportamento Contraceptivo , Anticoncepcionais Femininos/efeitos adversos , Contraceptivos Hormonais/efeitos adversos , Dispositivos Anticoncepcionais , Desogestrel/efeitos adversos , Feminino , HumanosRESUMO
OBJECTIVE: To describe risk factors and outcomes of pregnant women infected with SARS-CoV-2 admitted to South African healthcare facilities. METHODS: A population-based cohort study was conducted utilizing an amended International Obstetric Surveillance System protocol. Data on pregnant women with SARS-CoV-2 infection, hospitalized between April 14, 2020, and November 24, 2020, were analyzed. RESULTS: A total of 36 hospitals submitted data on 673 infected hospitalized pregnant women; 217 (32.2%) were admitted for COVID-19 illness and 456 for other indications. There were 39 deaths with a case fatality rate of 6.3%: 32 (14.7%) deaths occurred in women admitted for COVID-19 illness compared to 7 (1.8%) in women admitted for other indications. Of the women, 106 (15.9%) required critical care. Maternal tuberculosis, but not HIV co-infection or other co-morbidities, was associated with admission for COVID-19 illness. Rates of cesarean delivery did not differ significantly between women admitted for COVID-19 and those admitted for other indications. There were 179 (35.4%) preterm births, 25 (4.7%) stillbirths, 12 (2.3%) neonatal deaths, and 162 (30.8%) neonatal admissions. Neonatal outcomes did not differ significantly from those of infected women admitted for other indications. CONCLUSION: The maternal mortality rate was high among women admitted with SARS-CoV-2 infection and higher in women admitted primarily for COVID-19 illness with tuberculosis being the only co-morbidity associated with admission.
Assuntos
COVID-19 , Complicações Infecciosas na Gravidez , Nascimento Prematuro , Estudos de Coortes , Feminino , Humanos , Recém-Nascido , Transmissão Vertical de Doenças Infecciosas , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Resultado da Gravidez/epidemiologia , Gestantes , SARS-CoV-2 , África do Sul/epidemiologiaRESUMO
OBJECTIVE: An audit of second stage caesarean section (C/S) at a tertiary hospital was undertaken to compare the frequency of perinatal and maternal complications between first and second stage C/S and to evaluate the training level of physicians. METHODS: A prospective chart audit of all women who underwent emergency C/S over a 7-month period at a tertiary hospital was conducted. The patients' hospital records were assessed on a daily basis and all relevant information recorded on a structured data sheet categorising demographics, indications for C/S, level of training of decision-maker and surgeon, a consultant's presence, operative complications and neonatal outcome at 5 min post-delivery. The frequency of maternal and neonatal complications was the main outcome measures. RESULTS: There were 975 first stage and 116 second stage C/S. The commonest causes of second stage C/S were cephalo-pelvic disproportion, prolonged second stage and fetal distress. First stage C/S took a mean time of 35.5 min, while second stage C/S took an average time of 41.6 min to perform (p=0.001). There were 37 and 84 records of complications occurring in first and second stage C/S, respectively. CONCLUSION: Maternal complications were significantly higher in second stage C/S while neonatal complications were not significantly different between first and second stage C/S. There was little guidance from consultants at decision-making for second stage C/S.
Assuntos
Cesárea/estatística & dados numéricos , Segunda Fase do Trabalho de Parto , Complicações do Trabalho de Parto/cirurgia , Adolescente , Adulto , Serviços Médicos de Emergência/estatística & dados numéricos , Feminino , Hospitais de Ensino/estatística & dados numéricos , Humanos , Incidência , Primeira Fase do Trabalho de Parto , Auditoria Médica , Pessoa de Meia-Idade , Complicações do Trabalho de Parto/epidemiologia , Gravidez , Estudos Prospectivos , África do Sul/epidemiologia , Adulto JovemRESUMO
The management of the unconscious pregnant patient encompasses many aspects of obstetrics and critical care. It is not uncommon to have to manage such a patient, therefore one needs to be well prepared. There is a spectrum of altered consciousness, brain death being the most extreme. The causes of unconsciousness can be general or pregnancy specific. It is important to consider the physiological changes in pregnancy when managing these patients. The immediate resuscitative measures are mostly the same as for the nonpregnant with a few modifications. It is important to remember that there are two patients involved and this can complicate management issues. A multidisciplinary approach would be prudent. The intermediate and long-term management should also involve the family. The issues of perimortem and somatic support for foetal maturity are also discussed.
Assuntos
Cuidados Críticos/métodos , Complicações Cardiovasculares na Gravidez/terapia , Complicações Hematológicas na Gravidez/terapia , Ressuscitação/métodos , Inconsciência/terapia , Algoritmos , Cesárea , Eclampsia/terapia , Feminino , Maturidade dos Órgãos Fetais , Viabilidade Fetal/fisiologia , Humanos , Guias de Prática Clínica como Assunto , Gravidez , Complicações Cardiovasculares na Gravidez/etiologia , Complicações Cardiovasculares na Gravidez/fisiopatologia , Complicações Hematológicas na Gravidez/etiologia , Complicações Hematológicas na Gravidez/mortalidade , Ressuscitação/ética , Índice de Gravidade de Doença , Inconsciência/etiologiaRESUMO
The aim of this study was to establish a population-based incidence of severe acute maternal morbidity (SAMM) in hypertensive pregnancies and to assess if substandard care was unique to cases of SAMM and mortality or whether it was apparent in uncomplicated pregnancies as well. The population-based incidence of hypertension was 12%. Using defined criteria for SAMM, the incidence of SAMM was 3/1000 deliveries. The MMR was 42/100000 deliveries, i.e. SAMM is seven times greater than the mortality. Substandard care was similar in cases of SAMM and mortality and uncomplicated hypertensive patients. Audit of SAMM is informative, can be conducted more frequently, and in small sample population groups. It also allows interviews of patients, hence problems of inefficient documentation is obviated.